HIV News and Research

RSS

Special issue of JANAC summarizes 40 years of nursing science throughout the HIV epidemic

From the very beginning of the AIDS epidemic in 1981, nurses have been at the forefront of patient care, advocacy, and research.

5 May 2021

Researchers improve HIV care using mobile gaming application

Researchers at the University of North Carolina at Chapel Hill and Duke University improved HIV care by gamifying it with a mobile gaming application.

4 May 2021

ATS publishes new clinical practice guideline on community-acquired pneumonia

In its latest clinical practice guideline on community-acquired pneumonia the American Thoracic Society's guidelines panel addresses the use of nucleic acid-based testing for non-influenza viral pathogens.

4 May 2021

New findings on the support and barriers to combat TB in high-burden countries

Nine out of ten cases of tuberculosis appear in 30 identified low and middle-income countries, each of which has a national tuberculosis programme.

3 May 2021

SARS-CoV-2 spike mutations during transmission among humans and to animals

A fascinating new study discusses the 40 mutations that are seen on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and their potential effects on viral biology.

3 May 2021

Detecting rare blood clots was a win, but US vaccine safety system still has gaps

The quick detection of an ultra-rare blood clotting reaction in some Covid-19 vaccine recipients showed the power of a federal warning system for vaccine safety issues, but experts worry that blind spots in the program could hamper detection of other unexpected side effects.

3 May 2021

Study aims to refine delivery of tobacco treatment to people with HIV

Researchers at MUSC Hollings Cancer Center have received more than $2 million from the National Cancer Institute (NCI) to evaluate the impact of a proactive opt-out approach to smoking cessation on the health outcomes of people living with HIV.

30 Apr 2021

Researchers discover how SARS-CoV-2 hijacks human cell machinery to blunt immune response

Researchers at University of California San Diego School of Medicine have discovered one way in which SARS-CoV-2, the coronavirus that causes COVID-19, hijacks human cell machinery to blunt the immune response, allowing it to establish infection, replicate and cause disease.

29 Apr 2021

Non-traditional risk factors impact African American patients with coronary artery disease

A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American patients is being presented today at the Society for Cardiovascular Angiography and Interventions 2021 Virtual Scientific Sessions.

28 Apr 2021

Scientists identify blood cells most likely to be targeted by HIV during a real-life infection

In the 40-some years since the beginning of the HIV/AIDS epidemic, scientists have learned a lot about the virus, the disease, and ways to treat it. But one thing they still don't completely understand is which exact cells are most susceptible to HIV infection.

28 Apr 2021

Horizontal transmission route is responsible for HTLV-1 uveitis

Human T-cell lymphotropic virus type-1 (HTLV-1) is a retrovirus similar to human immunodeficiency virus (HIV) and has mostly been thought to be transmitted vertically (mother-to-child), or horizontally (sexually or parenterally (e.g. via blood transfusion)).

28 Apr 2021

ANTICOV clinical trial to test new treatment for people with mild-to-moderate COVID-19 in Africa

The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test a new drug combination, nitazoxanide + ciclesonide, to treat people with mild-to-moderate COVID-19 before their cases become severe.

27 Apr 2021

Scientists uncover an important clue to the conundrum of mother-to-child HIV transmission

Each year over 150,000 infants worldwide are infected with HIV in the womb, at birth, or through breastfeeding.

26 Apr 2021

Stigma, discrimination impede engagement in HIV prevention and treatment

Stigma and discrimination, such as homophobia and racism, impede engagement in HIV prevention and use of biomedical tools for treatment in both HIV-negative and HIV-positive gay and bisexual men, according to a Rutgers study.

26 Apr 2021

Host cell transmembrane protein MARCH8 targets lysine residues to inhibit SARS-CoV-2 and other viruses

A new study deals with the inhibitory activity of a membrane protein that has broad-spectrum activity against multiple viruses, showing that this is due to its effect on cytoplasmic lysine residue incorporation into replicating virions.

26 Apr 2021

Fighting malaria in 2021: Where are we now and where are we going?

In support of World Malaria Day, News-Medical spoke to Dr. Laurence Slutsker, an internationally recognized expert in malaria, about fighting this disease in 2021.

26 Apr 2021

Disruptions to essential health services due to COVID-19 pandemic persist in 90% of countries

The second round of a World Health Organization "pulse survey" reveals that over one year into the COVID-19 pandemic, substantial disruptions persist, with about 90% of countries still reporting one or more disruptions to essential health services, marking no substantial global change since the first survey conducted in the summer of 2020.

23 Apr 2021

HIV News and Research

Special issue of JANAC summarizes 40 years of nursing science throughout the HIV epidemic

Researchers improve HIV care using mobile gaming application

ATS publishes new clinical practice guideline on community-acquired pneumonia

New findings on the support and barriers to combat TB in high-burden countries

SARS-CoV-2 spike mutations during transmission among humans and to animals

Detecting rare blood clots was a win, but US vaccine safety system still has gaps

Study aims to refine delivery of tobacco treatment to people with HIV

Researchers discover how SARS-CoV-2 hijacks human cell machinery to blunt immune response

Non-traditional risk factors impact African American patients with coronary artery disease

Scientists identify blood cells most likely to be targeted by HIV during a real-life infection

Horizontal transmission route is responsible for HTLV-1 uveitis

ANTICOV clinical trial to test new treatment for people with mild-to-moderate COVID-19 in Africa

Scientists uncover an important clue to the conundrum of mother-to-child HIV transmission

Stigma, discrimination impede engagement in HIV prevention and treatment

Host cell transmembrane protein MARCH8 targets lysine residues to inhibit SARS-CoV-2 and other viruses

Fighting malaria in 2021: Where are we now and where are we going?

Disruptions to essential health services due to COVID-19 pandemic persist in 90% of countries

Only one vaccine is OK for older teens. It’s also the hardest to manage in rural America.

Celastrol shows potential anti-SARS-CoV-2 activity

New Phase 3 trial of therapeutics begins enrolling severely ill hospitalized COVID-19 patients

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News